Insights & Publications

Pharmaceuticals & Medical Products


The role of big data in medicine

November 2015—Technology is revolutionizing our understanding and treatment of disease, says the founding director of the Icahn Institute for Genomics and Multiscale Biology at New York’s Mount Sinai Health System.more

  • includes:

Editor's choice

Road to digital success_1536x1536_Thumbnail

The road to digital success in pharma

August 2015—Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires identifying the right initiatives.more


Pharma’s next challenge

July 2015—Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus to an access-driven commercial model must occur.more


Novartis on digitizing medicine in an aging world

June 2015—CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.more

  • includes:

Africa: A continent of opportunity for pharma and patients

June 2015—Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving that strength and how companies should react.more


Maintaining momentum in Brazil’s pharmaceutical market

April 2015—Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit growth is possible, but will require a granular approach.more

article | McKinsey Quarterly

Japan: Lessons from a hyperaging society

March 2015—The country’s population, already the world’s oldest, is aging quickly. Companies in Europe, North America, and Asia can learn from its experience.more

Capturing the new value segment_1536x1536_Thumbnail

Capturing the new ‘value’ segment in medical devices

January 2015—The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.more

Medical-device manufacturers_1536x1536_Thumbnail

How medical-device manufacturers can transform marketing and sales capabilities

January 2015—Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.more


Rapid growth in biopharma: Challenges and opportunities

December 2014—Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations.more


A digital prescription for pharma companies

November 2014—Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving. more


Value creation in medical device M&A

September 2014—Successful large, transformative deals are rare in medical devices. With further consolidation ahead, future acquirers need to reconsider their approach in the context of a programmatic M&A strategy.more

article | McKinsey Quarterly

Confronting change fatigue in the pharmaceutical industry

September 2014—A decade of restructuring and transformation efforts has taken a toll on organizational health.more

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.